906
Views
8
CrossRef citations to date
0
Altmetric
Author's View

Chimeric antigen receptor engineered T cells can eliminate brain tumors and initiate long-term protection against recurrence

, , &
Article: e944059 | Received 29 May 2014, Accepted 03 Jun 2014, Published online: 17 Jul 2014

Figures & data

Figure 1. Proposed model: EGFRvIII CAR modified T-cell immunotherapy of GBM leads to immunogenic cell death and epitope spreading. EGFRvIII+ CAR targeted destruction of GBM [1] results in release of immunostimulatory cytokines by T cells and antigens and DAMPs by dying tumor cells [2]. APCs are recruited to the site of tumor destruction where they engulf dying tumor cells and become activated by DAMPs [3]. Mature DCs expressing multiple MHC-restricted tumor antigens traffic to the LN [4] where they prime naïve T cells recognizing novel tumor antigens [5]. Newly activated T cells traffic to tumor and destroy GBM based upon recognition of novel tumor antigens [6]. APC, antigen presenting cell; CAR, chimeric antigen receptor; DAMP, danger associated molecular pattern; DC, dendritic cell; EGFRvIII, epidermal growth factor receptor variant 3; GBM, glioblastoma multiforme; IFNɣ, interferon gamma; IL2, interleukin-2; LN, lymph node; TC, cytolytic T cell; TH, helper T cell; TNFα, tumor necrosis factor α.

Figure 1. Proposed model: EGFRvIII CAR modified T-cell immunotherapy of GBM leads to immunogenic cell death and epitope spreading. EGFRvIII+ CAR targeted destruction of GBM [1] results in release of immunostimulatory cytokines by T cells and antigens and DAMPs by dying tumor cells [2]. APCs are recruited to the site of tumor destruction where they engulf dying tumor cells and become activated by DAMPs [3]. Mature DCs expressing multiple MHC-restricted tumor antigens traffic to the LN [4] where they prime naïve T cells recognizing novel tumor antigens [5]. Newly activated T cells traffic to tumor and destroy GBM based upon recognition of novel tumor antigens [6]. APC, antigen presenting cell; CAR, chimeric antigen receptor; DAMP, danger associated molecular pattern; DC, dendritic cell; EGFRvIII, epidermal growth factor receptor variant 3; GBM, glioblastoma multiforme; IFNɣ, interferon gamma; IL2, interleukin-2; LN, lymph node; TC, cytolytic T cell; TH, helper T cell; TNFα, tumor necrosis factor α.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.